Lecap Asset Management Ltd. Purchases Shares of 25,833 Perrigo Company plc (NYSE:PRGO)

Lecap Asset Management Ltd. acquired a new position in shares of Perrigo Company plc (NYSE:PRGO - Free Report) in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor acquired 25,833 shares of the company's stock, valued at approximately $724,000.

A number of other hedge funds and other institutional investors have also bought and sold shares of the company. Headlands Technologies LLC boosted its position in shares of Perrigo by 1,942.0% in the fourth quarter. Headlands Technologies LLC now owns 1,409 shares of the company's stock valued at $36,000 after acquiring an additional 1,340 shares during the period. Parallel Advisors LLC raised its stake in Perrigo by 176.9% during the 1st quarter. Parallel Advisors LLC now owns 1,714 shares of the company's stock valued at $48,000 after purchasing an additional 1,095 shares during the last quarter. Fifth Third Bancorp boosted its holdings in Perrigo by 62.0% in the 1st quarter. Fifth Third Bancorp now owns 2,218 shares of the company's stock valued at $62,000 after purchasing an additional 849 shares during the period. Blue Trust Inc. grew its position in Perrigo by 110.4% in the 1st quarter. Blue Trust Inc. now owns 2,619 shares of the company's stock worth $73,000 after purchasing an additional 1,374 shares during the last quarter. Finally, Central Pacific Bank Trust Division increased its holdings in shares of Perrigo by 50.0% during the 1st quarter. Central Pacific Bank Trust Division now owns 3,000 shares of the company's stock worth $84,000 after purchasing an additional 1,000 shares during the period. 95.91% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

Separately, Wall Street Zen upgraded shares of Perrigo from a "hold" rating to a "buy" rating in a research note on Saturday, May 24th. Three analysts have rated the stock with a hold rating and two have assigned a buy rating to the company's stock. According to MarketBeat, the stock presently has an average rating of "Hold" and an average price target of $33.00.

Perrigo Stock Performance

PRGO stock traded down $0.01 during midday trading on Friday, hitting $26.57. The stock had a trading volume of 136,357 shares, compared to its average volume of 1,457,382. Perrigo Company plc has a 52 week low of $23.14 and a 52 week high of $30.93. The company has a current ratio of 2.36, a quick ratio of 1.28 and a debt-to-equity ratio of 0.82. The stock has a 50-day simple moving average of $26.28 and a 200 day simple moving average of $26.03. The firm has a market capitalization of $3.65 billion, a price-to-earnings ratio of -20.28 and a beta of 0.46.

Perrigo (NYSE:PRGO - Get Free Report) last released its quarterly earnings data on Wednesday, May 7th. The company reported $0.60 EPS for the quarter, topping analysts' consensus estimates of $0.56 by $0.04. Perrigo had a negative net margin of 4.16% and a positive return on equity of 8.93%. The company had revenue of $1.04 billion during the quarter, compared to the consensus estimate of $1.09 billion. During the same period last year, the firm earned $0.29 EPS. The firm's revenue for the quarter was down 3.5% compared to the same quarter last year. As a group, equities research analysts anticipate that Perrigo Company plc will post 2.56 earnings per share for the current year.

Perrigo Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Tuesday, June 17th. Shareholders of record on Friday, May 30th were given a $0.29 dividend. This represents a $1.16 dividend on an annualized basis and a yield of 4.37%. The ex-dividend date of this dividend was Friday, May 30th. Perrigo's dividend payout ratio (DPR) is -88.55%.

Perrigo Profile

Perrigo Company plc provides over-the-counter health and wellness solutions to enhance individual well-being in the United States, Europe, and internationally. It operates through Consumer Self-Care Americas and Consumer Self-Care International segments. The company develops, manufactures, markets, and distributes self-care consumer products, such as upper respiratory products, including cough suppressants, expectorants, and sinus and allergy relief; nutrition products consisting of infant formulas and nutritional beverages; digestive health products, including antacids, anti-diarrheal, and anti-heartburn; pain and sleep-aids products comprising pain relievers and fever reducers; and oral care products, which include toothbrushes, toothbrush replacement heads, floss, flossers, whitening products, and toothbrush covers.